Association between Physical Activity and Comorbidities in Spanish People with Asthma-COPD Overlap

• Published in: Sustainability Vol. 13; no. 14; p. 7580
• Main Authors: Sánchez Castillo, Sheila, Smith, Lee, Díaz Suárez, Arturo, López Sánchez, Guillermo Felipe
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 07.07.2021
• Subjects: Adults; Alcohol; Anxiety; Asthma; Biomedical materials; Cardiovascular disease; Cataracts; Chronic conditions; Chronic illnesses; Chronic obstructive pulmonary disease; Constipation; Diabetes; Epidemiology; Exercise; Health surveys; Hypersensitivity; Hypertension; Lung diseases; Metabolism; Obstructive lung disease; Osteoporosis; Pain; Physical activity; Quality of life; Questionnaires; Regression analysis; Respiratory diseases; Rhinitis; Sustainability; Sustainable development; Tobacco; Urinary incontinence; Spain
• ISSN: 2071-1050; 2071-1050
• DOI: 10.3390/su13147580

Asthma and chronic obstructive pulmonary disease (COPD) are important conditions which often coexist. Higher rates of comorbidities among people with asthma-COPD overlap (ACO) may complicate clinical management. The aim of this study was to determine the prevalence of 30 different comorbidities and to analyze associations between these comorbidities and physical activity (PA) in Spanish people with ACO. Cross-sectional data from the Spanish National Health Survey 2017 were analyzed. A total of 198 Spanish people with ACO aged 15–69 years (60.6% women) were included in this study. PA was measured with the International Physical Activity Questionnaire (IPAQ) short form. Diagnosis of chronic conditions were self-reported. Associations between PA and comorbidities were analyzed using multivariable logistic regression models. The most prevalent comorbidities were chronic allergy (58.1%), chronic lumbar pain (42.4%), chronic cervical pain (38.4%), hypertension (33.3%) and arthrosis (31.8%). A PA level lower than 600 MET·min/week was significantly associated with urinary incontinence (OR = 3.499, 95% CI = 1.369–8.944) and osteoporosis (OR = 3.056, 95% CI = 1.094–8.538) in the final adjusted model. Therefore, the potential influence of PA on reducing the risk of these conditions among people with ACO should be considered, not only because of the health benefits, but also because PA can contribute to a more sustainable world.